Lori M. Henderson

Lori M. Henderson (senior executive) discloses dealings in 2 companies, chiefly Moderna, Inc. and Albany Molecular Research Inc. Between 31 January 2016 and 27 May 2021, the trades on record add up to 12 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

On 28 May 2021 came the latest disclosure, an option exercise for €80k in Moderna, Inc. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.